Prudential Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,754
| Closed | -$324K | – | 2756 |
|
|
2022
Q3 | $324K | Buy |
+4,754
| New | +$262K | ﹤0.01% | 2272 |
|
|
2020
Q2 | – | Sell |
-4,543
| Closed | -$233K | – | 2492 |
|
|
2020
Q1 | $233K | Sell |
4,543
-930
| -17% | -$62.3K | ﹤0.01% | 2143 |
|
|
2019
Q4 | $435K | Buy |
5,473
+377
| +7% | +$22.3K | ﹤0.01% | 2102 |
|
|
2019
Q3 | $248K | Sell |
5,096
-602
| -11% | -$31.4K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $300K | Buy |
5,698
+635
| +13% | +$36.5K | ﹤0.01% | 2230 |
|
|
2019
Q1 | $268K | Sell |
5,063
-261
| -5% | -$12.8K | ﹤0.01% | 2238 |
|
|
2018
Q4 | $219K | Buy |
+5,324
| New | +$199K | ﹤0.01% | 2223 |
|
|
2018
Q3 | – | Sell |
-4,853
| Closed | -$219K | – | 2482 |
|
|
2018
Q2 | $219K | Buy |
+4,853
| New | +$221K | ﹤0.01% | 2318 |
|
|
2018
Q1 | – | Sell |
-77,358
| Closed | -$3.14M | – | 2398 |
|
|
2017
Q4 | $3.14M | Sell |
77,358
-39,537
| -34% | -$1.48M | ﹤0.01% | 1367 |
|
|
2017
Q3 | $3.63M | Buy |
116,895
+6,900
| +6% | +$194K | 0.01% | 1284 |
|
|
2017
Q2 | $3.01M | Buy |
109,995
+34,749
| +46% | +$1.03M | ﹤0.01% | 1360 |
|
|
2017
Q1 | $2.77M | Sell |
75,246
-222,930
| -75% | -$5.61M | ﹤0.01% | 1402 |
|
|
2016
Q4 | $4.31M | Buy |
298,176
+167,651
| +128% | +$2.95M | 0.01% | 1179 |
|
|
2016
Q3 | $3.01M | Buy |
+130,525
| New | +$2.49M | 0.01% | 1308 |
|
Other funds holding GBT
Prudential Financial's GBT Position: Q4 2022 in Review
Prudential Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 4,754 shares — an estimated $324K sold.
Prudential Financial first reported a position in GBT in Q3 2016 and held it in 14 quarters. The position peaked at $4.31M in Q4 2016. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Prudential Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Prudential Financial sold 4,754 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $324K.
- Prudential Financial first reported a position in Global Blood Therapeutics, Inc. in Q3 2016 and held it in 14 quarters.
- Prudential Financial's Global Blood Therapeutics, Inc. position peaked at $4.31M in Q4 2016.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.